Neurocor Banaszkiewicz Tomaszewski Lekarze sp.p.
- Address
- Ul. Mieczyslawa Medweckiego 7/u12, 31-870 Krakow, Poland
Neurocor Banaszkiewicz Tomaszewski Lekarze sp.p. - Neurology Research Center
Neurocor Banaszkiewicz Tomaszewski Lekarze sp.p. is a specialized clinical research center dedicated to advancing treatments for complex neurological conditions. The center demonstrates particular expertise in conducting Phase III trials for both neurodegenerative diseases and neuromuscular disorders, with a strong focus on evaluating innovative therapeutic approaches that address unmet medical needs in neurology.
- Neuromuscular disorders, including generalized Myasthenia Gravis
- Neurodegenerative diseases, with emphasis on Alzheimer's disease and Parkinson's disease
- Headache disorders, including chronic and episodic migraine prevention
- Motor fluctuations and movement disorders in advanced Parkinson's disease
The center's research portfolio encompasses diverse therapeutic modalities, from botulinum toxin injections for migraine prevention to complement inhibitors for autoimmune conditions and novel formulations of levodopa/carbidopa for motor complications. With experience in evaluating treatments for cognitive impairment associated with Alzheimer's disease and addressing complex quality of life measures in Myasthenia Gravis, the center plays a vital role in bringing innovative neurological therapies from clinical development to patient care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Merz Therapeutics GmbH2active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merz Therapeutics GmbH2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Neurocor Banaszkiewicz Tomaszewski Lekarze sp.p.
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study of AUR200 in Generalized Myasthenia Gravis | Aurinia Pharmaceuticals Inc. | Phase I | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins | 2 | Unknown | 2025-10-06 | 2025-10-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
